0%
Daily Market Update
15-Sep-20261 min readvipin kumar

Brent Crude near $107 as Saudi pipeline shutdown keeps supply risks in focus – Daily Market Update 15th Sept 2026

Get a Smart Summary Instantly

Prompt copied

Oil prices edged higher on Tuesday as traders weighed the risk of further disruptions to Middle East supplies after a key Saudi Arabian pipeline was forced offline. Brent crude rose to around $107 a barrel, while West Texas Intermediate was near $103. The gains came after the market absorbed the impact of attacks that shut Saudi Arabia’s East-West pipeline, a critical alternative route for moving crude without using the Strait of Hormuz.

Overview and Outlook

Global Stock Market Today

  • US markets settled on a flat to negative note.
  • European equity markets, barring FTSE, ended lower.
  • Asian equity markets are trading with a positive bias.
  • GIFT Nifty is up by 70 points, Nifty futures likely to open around 23520 levels.

 

News highlights from across the globe

  • Wall Street ended lower on Monday, weighed down by losses in Nvidia and other ​chipmakers after top executives in U.S. artificial intelligence companies raised safety concerns and called for a slowdown in the ‌development of AI.
  • Asian equity markets are trading higher on Tuesday as investors weighed Middle East tensions and calls by industry figures for a slowdown in AI development, while elevated oil prices and higher bond yields added to caution before key central bank meetings in the U.S. and Japan.
  • Oil prices edged higher on Tuesday as traders weighed the risk of further disruptions to Middle East supplies after a key Saudi Arabian pipeline was forced offline. Brent crude rose to around $107 a barrel.

 

Important news updates from the domestic front

  • Dr Reddy’s- US FDA issues Form 2953 with two observations for API manufacturing unit in Mexico. US FDA inspected the unit between July 17 and September 8. Company to respond to observations within stipulated time.
  • Gabriel India allot shares worth Rs 1,881 Cr to promoter Asia Investments.
  • WeWork India- E-files application with NCLT for reduction in share capital. Reduction proposed to fully set off accumulated losses worth Rs 2,050 Cr.
  • Jamna Auto promoter sells 2.49% stake, shareholding reduces to 1.88%. Promoters are Randeep Singh Jauhar and Pradeep Singh Jauhar.
  • Waaree Renewable incorporates arm Sunstar Data Centres for data centre business. New entity to develop and operate data centres, including hyperscale, AI-ready and GPU hosting facilities.
  • Geojit Financial Services- CARE Ratings reaffirms issuer rating at CARE A+; stable.
  • Tata Chemicals- Tata Chemicals North America completes acquisition of North American soda ash customer contracts. Contracts represent over 5 Lakh tonnes to be serviced over two years.
  • NTPC-  NTPC Green Energy declares commercial operation of additional 6.3 MW of Vanki Wind Energy. NTPC Green Energy Group’s commercial capacity rises to 10,842.86 MW from 10,836.56 MW. NTPC Group’s installed capacity rises to 91,086 MW; commercial capacity to 90,006 MW.
  • HDFC Bank submits two names to RBI for MD and CEO post; seeks RBI nod for new MD and CEO appointment. Reappoints V Srinivasa Rangan as whole-time director till November 22, 2027. Appoints Jimmy Tata as whole-time director for three years. Board approves creation of fourth whole-time director position.
  • Grasim Industries customs department ends search at Ujjain manufacturing unit. Enquiry primarily relates to import-export transactions. Business operations to continue. Company sees no material impact on financials due to said action.
  • Venus Pipes shareholders approve appointment of Arun Axaykumar Kothari as chair and MD for five years. Promoters Megharam Sagramji Choudhary and Dhruv Mahendrakumar Patel reappointed as whole-time directors for five years.
  • Clean Science and Technology approves appointment of Krishnakumar Satyanarain Saboo as whole-time director for five years.
  •  Lumino Industries- CRISIL upgrades long-term bank facilities rating to A+/stable from A/stable. Short-term rating reaffirmed at A1. Rs 2,000 Cr of bank loan facilities rated. Order book stands at Rs 3,090 Cr as of June 30. Rs 500 Cr of IPO proceeds used for working capital, reducing debt reliance by Rs 360 Cr. Net worth expected to rise to over Rs 1,400 Cr by March 2027.
  • Balaji Amines- Ind-Ra withdraws ratings on bank loan facilities after company receives no-dues certificates from all bankers. Company says it has no outstanding bank exposure; Rs 195 Cr of bank loan facilities were previously rated.
  • JSW Energy’s arm JSW Neo Energy gets ICRA AA-/stable rating for unsupported long-term bank loan facilities. ICRA A1+ assigned and affirmed for proposed commercial paper and short-term/working capital facilities. AA(CE)/stable affirmed for long-term bank loans.
  • Eris Lifesciences- Krishnakumar Vaidyanathan resigns as COO from September 30 to pursue professional opportunities.
  • Greenply Industries issue corporate guarantee in favour of IDBI Bank for Rs 200 Cr. Announces proposed capital restructuring of JV Greenply Samet. Samet to invest additional $30-40 Mn in JV entity over the next two to three years. Restructuring transaction expected to be completed by January 2027. Samet will increase its voting interest from 50% to 81%, while Greenply’s voting interest will dilute from 50% to 19%.
  • Aurobindo Pharma- US FDA concludes inspection at arm Apitoria Pharma’s unit with zero observations. US FDA inspected the unit from September 7 to 11.
  • SJVN commence operations of Unit II of Buxar Power Project on September 12. Unit has a capacity of 660 MW.
  • Raymond gets aerospace orders from Indian aerospace and defence major. Annual business potential of order at Rs 33 Cr.
  •  Bank of Maharashtra- Government nominates Saurabh Kumar as director on the board.
  • TVS Motors launches expanded Apache portfolio in Sri Lanka, comprising four Apache motorcycles.
  • Coforge- DK Singh resigns as chairperson of nomination and remuneration committee. Interim chair Vivek Sharma to lead search for independent directors and oversee process of electing new chair. Company says Singh’s resignation has no other material reason.
  • Jubilant Pharmova- US FDA classifies US CMO unit as Voluntary Action Indicated. US FDA inspected the unit from June 8 to 17. DK Singh points to differences on company’s board in resignation letter. Board designates Beth Boucher as non-executive independent director and chair of NRC.
  • Sun Pharma- Three arms settle US antitrust litigation. Settles US pricing lawsuit in Pennsylvania. Company to make confidential payment; other terms of settlement remain confidential.
  • HDFC Life Insurance gets total tax demand of Rs 3,365 Cr, including penalty. Tax demand at Rs 942.18 Cr; interest and penalty at Rs 2,422.97 Cr.
  • Cochin Shipyard executes JV agreement with Drydocks World Dubai.
  • Strides Pharma receives US FDA EIR for Bengaluru flagship facility after VAI inspection closure.
  • RBL Bank careEdge assigns CareEdge BBB+/stable rating to $350 Mn foreign currency notes.
  • Welspun Corp wholly-owned subsidiary Welspun DI Pipes approves incorporation of Welspun Special Coating to undertake pipe coating and protective coating solutions business. Proposed coating portfolio includes polyolefin, FBE, internal FBE, polyurethane, polyethylene, polypropylene and anti-corrosive coatings.

 

Nifty Overview & Outlook

Following a gap-down opening around the price support zone placed around 23200-23000 spot levels, Nifty index filled the entire gap in day trade and settled at 23398 spot levels after a cut of 80 points from its previous closing values.

The broader markets traded in line with the benchmark as Mid and Small cap indices fell 0.26% & 0.58% respectively.

The majority of sectoral indices, tracked at NSE, ended in red. Among them, Nifty Realty and Metal were the worst performers, down 2.70% & 2.30% respectively followed by Chemicals, Auto and Oil & Gas index that were down around 1% each.

Going ahead, cross and sustenance above 23500 spot levels could lead the bounce back rally towards 23700-23800 spot zone that will act as a strong resistance zone on the higher side and any bounce back rally towards these levels will attract sellers interest around those levels.

 

Derivatives Overview & Outlook

Last Friday, Banknifty and Midcapnifty futures added around 1% and 4.5% of open interest respectively as long buildup. On the other hand, no significant changes were observed in Nifty and Finnifty futures on price as well as on open interest front.

Performance on the sectoral front was mix. Among them, Chemical stocks witnessed maximum addition of short positions, whereas some short covering was seen among Telecom stocks.

On options front, put writing along with some call unwinding was seen at multiple OTM strikes. Maximum positions are at 24000 CE followed by 23800 CE and 23300 PE followed by 23000 PE.

 

Institutional Trading Activity

Last week, FIIs sold stocks worth Rs 177 Cr in the cash segment, sold stocks futures worth Rs 6080 Cr and also sold index futures worth Rs 7650 Cr. DIIs were net buyers in the cash segment to the tune of Rs 6420 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 23580-23700; Supports 23400-23300

Banknifty – Resistances 57200-57500; Supports 56500-56000

Finnifty – Resistances 25750-25850; Supports 25400- 25200

 

F&O stocks in ban today: KAYNES, INOXWIND, MANAPPURAM FIN, SAIL & BANDHANBANK

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates. AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited are the associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection GC does not take any responsibility thereof. This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months. GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months. Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our research analysts may use AI tools to collect, summarize, and present data in order to increase productivity and enhance the clarity and readability of our reports. However, all reports are subject to human review prior to finalization and distribution to end users.

Our published research reports are the property of GCML and its associate and subsidiary companies. These reports may not be copied, reproduced, distributed or otherwise used by any other brokerage or individual firm without the prior written permission of GCML or its associate/subsidiary companies.